MiNK Therapeutics, Inc. - Stock (INKT)

CUSIP: 603693102

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Stock
Total 13F shares
1,477,425
Share change
+869,813
Total reported value
$3,096,334
Price per share
$2.10
Number of holders
43
Value change
+$1,864,911
Number of buys
41
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 603693102?
CUSIP 603693102 identifies INKT - MiNK Therapeutics, Inc. - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MiNK Therapeutics, Inc. - Stock (INKT) as of Q2 2023

As of 30 Jun 2023, MiNK Therapeutics, Inc. - Stock (INKT) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,477,425 shares. The largest 10 holders included Deep Track Capital, LP, VANGUARD GROUP INC, Artal Group S.A., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., CITADEL ADVISORS LLC, ORACLE INVESTMENT MANAGEMENT INC, CAPTRUST FINANCIAL ADVISORS, and STATE STREET CORP. This page lists 43 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.